Patient Groups Raise Ante Against Gilead’s India Deals
This article was originally published in PharmAsia News
Executive Summary
International patient groups are up in arms alleging that the multiple deals entered into by Gilead with Indian drug makers endanger lower cost copies of future hepatitis C and HIV treatments.